Eda Hirotsugu, Fukui Hirokazu, Uchiyama Ryosuke, Kitayama Yoshitaka, Hara Ken, Yang Mo, Kodani Mio, Tomita Toshihiko, Oshima Tadayuki, Watari Jiro, Tsutsui Hiroko, Miwa Hiroto
Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Department of Microbiology, Hyogo College of Medicine, Nishinomiya, Japan.
PLoS One. 2017 May 18;12(5):e0177232. doi: 10.1371/journal.pone.0177232. eCollection 2017.
Although Helicobacter pylori (H. pylori) infection is closely associated with the development of peptic ulcer, its involvement in pathophysiology in the lower intestinal tract and gastrointestinal (GI) motility remains unclear. Glucagon-like peptide-1 (GLP-1) is a gut hormone produced in the lower intestinal tract and involved in GI motility. Here, we investigated the effect of H. pylori infection on the link between GLP-1 expression and motility of the GI tract.
C57BL/6 mice were inoculated with a H. pylori strain. Twelve weeks later, the H. pylori-infected mice underwent H. pylori eradication treatment. GI tissues were obtained from the mice at various time intervals, and evaluated for the severity of gastric inflammatory cell infiltration and immunohistochemical expression of GLP-1 and PAX6 in the colonic mucosa. Gastrointestinal transit time (GITT) was measured by administration of carmine-red solution.
GLP-1 was expressed in the endocrine cells of the colonic mucosa, and PAX6 immunoreactivity was co-localized in such cells. The numbers of GLP-1- and PAX6-positive cells in the colon were significantly increased at 12 weeks after H. pylori infection and showed a positive correlation with each other. The GITT was significantly longer in H. pylori-infected mice than in non-infected controls and showed a positive correlation with GLP-1 expression. When H. pylori-infected mice underwent H. pylori eradication, GITT and PAX6/GLP-1 expression did not differ significantly from those in untreated H. pylori-infected mice.
H. pylori infection may impair GI motility by enhancing the colonic GLP-1/PAX6 expression.
尽管幽门螺杆菌(H. pylori)感染与消化性溃疡的发生密切相关,但其在肠道下段病理生理学及胃肠(GI)动力方面的作用仍不清楚。胰高血糖素样肽-1(GLP-1)是一种在肠道下段产生并参与胃肠动力调节的肠激素。在此,我们研究了幽门螺杆菌感染对GLP-1表达与胃肠道动力之间联系的影响。
将幽门螺杆菌菌株接种于C57BL/6小鼠。12周后,对感染幽门螺杆菌的小鼠进行幽门螺杆菌根除治疗。在不同时间间隔从小鼠获取胃肠道组织,评估胃炎症细胞浸润的严重程度以及结肠黏膜中GLP-1和PAX6的免疫组化表达。通过给予胭脂红溶液测量胃肠传输时间(GITT)。
GLP-1在结肠黏膜的内分泌细胞中表达,PAX6免疫反应性与这些细胞共定位。幽门螺杆菌感染12周后,结肠中GLP-1和PAX6阳性细胞数量显著增加,且两者呈正相关。幽门螺杆菌感染小鼠的GITT显著长于未感染对照小鼠,且与GLP-1表达呈正相关。当感染幽门螺杆菌的小鼠接受幽门螺杆菌根除治疗后,GITT以及PAX6/GLP-1表达与未治疗的感染小鼠相比无显著差异。
幽门螺杆菌感染可能通过增强结肠GLP-1/PAX6表达来损害胃肠动力。